Compositions and methods for peptide expression and purification using a type III secretion system
US-10800818-B2 · Oct 13, 2020 · US
US11293028B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11293028-B2 |
| Application number | US-201615765132-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 3, 2016 |
| Priority date | Oct 2, 2015 |
| Publication date | Apr 5, 2022 |
| Grant date | Apr 5, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the effects of codon context and synonymous codon changes on mRNA translation and methods of increasing protein production.
Opening claim text (preview).
What is claimed is: 1. A recombinant nucleic acid molecule comprising a mutant triacontanucleotide sequence having at least ten codons, wherein at least one of the sixth, seventh, eighth, ninth and tenth codons, in the 5′ to 3′ direction, are synonymous codons, and wherein the mutant triacontanucleotide sequence is selected from SEQ ID NOs: 8-15. 2. The recombinant molecule of claim 1 , wherein the mutant triacontanucleotide sequence is operably linked to a heterologous polynucleotide sequence that encodes a polypeptide of interest. 3. The recombinant molecule of claim 2 , wherein the polypeptide of interest is insulin. 4. A vector comprising the recombinant molecule of claim 1 . 5. An isolated host cell comprising the recombinant molecule of claim 1 . 6. A vector comprising the recombinant molecule of claim 2 . 7. An isolated host cell comprising the recombinant molecule of claim 2 . 8. A method of modulating protein production within a host cell, comprising culturing a host cell under conditions sufficient for protein expression, wherein the recombinant molecule of claim 4 has been stably introduced into the host cell. 9. A method of increasing the translation speed of a polynucleotide sequence, comprising providing to a host cell a polynucleotide sequence that encodes a protein and is operably linked to a wild type triacontanucleotide sequence comprising ten codons and encoding SEQ ID NO:1, and mutating the triacontanucleotide sequence so that the mutant triacontanucleotide sequence is selected from SEQ ID NOs: 8-15, and culturing the host cell under conditions to express the polynucleotide sequence. 10. A method for increasing specific cellular productivity of a polypeptide of interest in a host cell comprising: (a) providing a polynucleotide sequence that encodes the polypeptide of interest and is operably linked to a wild type triacontanucleotide sequence comprising ten codons and encoding SEQ ID NO:1, (b) mutating the triacontanucleotide sequence so that the mutant triacontanucleotide sequence is selected from SEQ ID NOs: 8-15; (c) introducing the polynucleotide sequence into the host cell; (d) incubating the cell under conditions wherein the introduced polynucleotide is expressed; and (e) isolating the polypeptide of interest.
Escherichia (G) · CPC title
having 5 to 11 amino acids · CPC title
containing protease site · CPC title
Insulins · CPC title
Fusion polypeptide · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.